Similar articles

• [After the early termination of the Women's Health Initiative study. New American recommendations for postmenopausal hormone therapy].

  Stjernquist M; North American Menopause Society (NAMS) Advisory Panel. Stjernquist M, et al. Lakartidningen. 2003 May 15;100(20):1790-7. Lakartidningen. 2003. PMID: 12806859 Swedish.
• [Hormone replacement therapy: the pros].

  Jamin C, Madelenat P. Jamin C, et al. Gynecol Obstet Fertil. 2008 Jan;36(1):98-103. doi: 10.1016/j.gyobfe.2007.11.008. Gynecol Obstet Fertil. 2008. PMID: 18248839 French. No abstract available.
• Women's Health Initiative: not over yet. The largest study of women's health has raised at least as many questions as it has answered. Stay tuned.

  [No authors listed] [No authors listed] Harv Womens Health Watch. 2006 May;13(9):1-4. Harv Womens Health Watch. 2006. PMID: 16696133 No abstract available.
• Hormone therapy in the WHI era.

  Burger HG. Burger HG. Aust N Z J Obstet Gynaecol. 2006 Apr;46(2):84-91. doi: 10.1111/j.1479-828X.2006.00533.x. Aust N Z J Obstet Gynaecol. 2006. PMID: 16638027 Review.
• The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?

  Shulman LP. Shulman LP. J Fam Pract. 2004 Jul;Suppl:S13-7. J Fam Pract. 2004. PMID: 15251108 Review. No abstract available.